272 related articles for article (PubMed ID: 34867947)
21. Defective response of CD4(+) T cells to retinoic acid and TGFβ in systemic lupus erythematosus.
Sobel ES; Brusko TM; Butfiloski EJ; Hou W; Li S; Cuda CM; Abid AN; Reeves WH; Morel L
Arthritis Res Ther; 2011 Jun; 13(3):R106. PubMed ID: 21708033
[TBL] [Abstract][Full Text] [Related]
22. Oral administration of different forms of a tolerogenic peptide to define the preparations and doses that delay anti-DNA antibody production and nephritis and prolong survival in SLE-prone mice.
Skaggs BJ; Lourenço EV; Hahn BH
Lupus; 2011 Aug; 20(9):912-20. PubMed ID: 21562020
[TBL] [Abstract][Full Text] [Related]
23. Harnessing Tolerogenic Histone Peptide Epitopes From Nucleosomes for Selective Down-Regulation of Pathogenic Autoimmune Response in Lupus (Past, Present, and Future).
Datta SK
Front Immunol; 2021; 12():629807. PubMed ID: 33936042
[TBL] [Abstract][Full Text] [Related]
24. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the levels of DNA-binding inhibitor Id3 and regulatory T cells with SLE disease severity.
Liu C; Yu S; Jin R; Long Y; Lu S; Song Y; Sun X; Sun XH; Zhang Y
J Autoimmun; 2020 Sep; 113():102498. PubMed ID: 32536579
[TBL] [Abstract][Full Text] [Related]
26. HLA DRB1*1503 allelic haplotype predominance and associated immunodysregulation in systemic lupus erythematosus.
Suggs MJ; Majithia V; Lewis RE; Cruse JM
Exp Mol Pathol; 2011 Oct; 91(2):548-62. PubMed ID: 21497601
[TBL] [Abstract][Full Text] [Related]
27. Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.
Horwitz DA; Bickerton S; Koss M; Fahmy TM; La Cava A
Arthritis Rheumatol; 2019 Apr; 71(4):632-640. PubMed ID: 30407752
[TBL] [Abstract][Full Text] [Related]
28. Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB x NZW) F1 mice.
Fujii T; Iida Y; Yomogida M; Ikeda K; Haga T; Jikumaru Y; Ninami M; Nishimura N; Kodera Y; Inada Y; Shirai T; Hirose S; Nishimura H
Genes Immun; 2006 Dec; 7(8):647-54. PubMed ID: 17024131
[TBL] [Abstract][Full Text] [Related]
29. Clinical amelioration of murine lupus by a peptide based on the complementarity determining region-1 of an autoantibody and by cyclophosphamide: similarities and differences in the mechanisms of action.
Sharabi A; Azulai H; Sthoeger ZM; Mozes E
Immunology; 2007 Jun; 121(2):248-57. PubMed ID: 17346282
[TBL] [Abstract][Full Text] [Related]
30. Unmasking of autoreactive CD4 T cells by depletion of CD25 regulatory T cells in systemic lupus erythematosus.
Engler JB; Undeutsch R; Kloke L; Rosenberger S; Backhaus M; Schneider U; Egerer K; Dragun D; Hofmann J; Huscher D; Burmester GR; Humrich JY; Enghard P; Riemekasten G
Ann Rheum Dis; 2011 Dec; 70(12):2176-83. PubMed ID: 21926188
[TBL] [Abstract][Full Text] [Related]
31. A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus.
Hanaoka H; Nishimoto T; Okazaki Y; Takeuchi T; Kuwana M
Arthritis Res Ther; 2020 Apr; 22(1):88. PubMed ID: 32317002
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of Foxp3+ CD4+ CD25+ regulatory cells in peripheral blood of patients with SLE].
Wei HG; Cai B; Wang LL; Li J; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):432-5. PubMed ID: 17488604
[TBL] [Abstract][Full Text] [Related]
33. Increased CD4
Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
[TBL] [Abstract][Full Text] [Related]
34. CD4+ T cells from (New Zealand Black x New Zealand White)F1 lupus mice and normal mice immunized against apoptotic nucleosomes recognize similar Th cell epitopes in the C terminus of histone H3.
Fournel S; Neichel S; Dali H; Farci S; Maillère B; Briand JP; Muller S
J Immunol; 2003 Jul; 171(2):636-44. PubMed ID: 12847228
[TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular mechanisms of regulation of autoantibody production in lupus.
Hahn BH; Ebling F; Singh RR; Singh RP; Karpouzas G; La Cava A
Ann N Y Acad Sci; 2005 Jun; 1051():433-41. PubMed ID: 16126985
[TBL] [Abstract][Full Text] [Related]
36. Phenotypical changes and clinical significance of CD4
Yuan S; Zeng Y; Li J; Wang C; Li W; He Z; Ye J; Li F; Chen Y; Lin X; Yu N; Cai X
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35732344
[TBL] [Abstract][Full Text] [Related]
37. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.
Lourenço EV; Liu A; Matarese G; La Cava A
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10637-42. PubMed ID: 27588900
[TBL] [Abstract][Full Text] [Related]
38. Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
Puwipirom H; Hirankarn N; Sodsai P; Avihingsanon Y; Wongpiyabovorn J; Palaga T
Arthritis Res Ther; 2010; 12(6):R215. PubMed ID: 21110900
[TBL] [Abstract][Full Text] [Related]
39. Regulatory T cells in systemic lupus erythematosus.
Ohl K; Tenbrock K
Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
[TBL] [Abstract][Full Text] [Related]
40. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells.
Sobel ES; Morel L; Baert R; Mohan C; Schiffenbauer J; Wakeland EK
J Immunol; 2002 Oct; 169(7):4025-32. PubMed ID: 12244205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
